vs

Side-by-side financial comparison of Health Catalyst, Inc. (HCAT) and LIVE VENTURES Inc (LIVE). Click either name above to swap in a different company.

LIVE VENTURES Inc is the larger business by last-quarter revenue ($108.5M vs $74.7M, roughly 1.5× Health Catalyst, Inc.). LIVE VENTURES Inc runs the higher net margin — -0.1% vs -121.9%, a 121.8% gap on every dollar of revenue. On growth, LIVE VENTURES Inc posted the faster year-over-year revenue change (-2.7% vs -6.2%). Health Catalyst, Inc. produced more free cash flow last quarter ($9.6M vs $8.5M). Over the past eight quarters, Health Catalyst, Inc.'s revenue compounded faster (-0.0% CAGR vs -4.3%).

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Fir...

Live Nation Entertainment, Inc. is an American multinational entertainment company that was founded in 2010 following the merger of Live Nation and Ticketmaster. It continues to operate both brands as subsidiary companies, promoting and managing ticket sales for live entertainment internationally. It also owns and operates entertainment venues and manages the careers of music artists.

HCAT vs LIVE — Head-to-Head

Bigger by revenue
LIVE
LIVE
1.5× larger
LIVE
$108.5M
$74.7M
HCAT
Growing faster (revenue YoY)
LIVE
LIVE
+3.5% gap
LIVE
-2.7%
-6.2%
HCAT
Higher net margin
LIVE
LIVE
121.8% more per $
LIVE
-0.1%
-121.9%
HCAT
More free cash flow
HCAT
HCAT
$1.1M more FCF
HCAT
$9.6M
$8.5M
LIVE
Faster 2-yr revenue CAGR
HCAT
HCAT
Annualised
HCAT
-0.0%
-4.3%
LIVE

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HCAT
HCAT
LIVE
LIVE
Revenue
$74.7M
$108.5M
Net Profit
$-91.0M
$-64.0K
Gross Margin
32.6%
Operating Margin
-115.3%
3.2%
Net Margin
-121.9%
-0.1%
Revenue YoY
-6.2%
-2.7%
Net Profit YoY
-340.3%
-113.0%
EPS (diluted)
$-1.29
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCAT
HCAT
LIVE
LIVE
Q4 25
$74.7M
$108.5M
Q3 25
$76.3M
$113.9M
Q2 25
$80.7M
$112.5M
Q1 25
$79.4M
$107.0M
Q4 24
$79.6M
$111.5M
Q3 24
$76.4M
$112.7M
Q2 24
$75.9M
$123.9M
Q1 24
$74.7M
$118.6M
Net Profit
HCAT
HCAT
LIVE
LIVE
Q4 25
$-91.0M
$-64.0K
Q3 25
$-22.2M
$997.0K
Q2 25
$-41.0M
$5.4M
Q1 25
$-23.7M
$15.9M
Q4 24
$-20.7M
$492.0K
Q3 24
$-14.7M
$-19.9M
Q2 24
$-13.5M
$-2.9M
Q1 24
$-20.6M
$-3.3M
Gross Margin
HCAT
HCAT
LIVE
LIVE
Q4 25
32.6%
Q3 25
52.6%
32.4%
Q2 25
34.0%
Q1 25
32.8%
Q4 24
31.7%
Q3 24
47.5%
31.9%
Q2 24
29.9%
Q1 24
29.9%
Operating Margin
HCAT
HCAT
LIVE
LIVE
Q4 25
-115.3%
3.2%
Q3 25
-22.9%
3.3%
Q2 25
-46.0%
7.1%
Q1 25
-25.4%
2.0%
Q4 24
-22.0%
0.7%
Q3 24
-17.9%
-15.5%
Q2 24
-20.8%
0.9%
Q1 24
-30.5%
-0.7%
Net Margin
HCAT
HCAT
LIVE
LIVE
Q4 25
-121.9%
-0.1%
Q3 25
-29.1%
0.9%
Q2 25
-50.8%
4.8%
Q1 25
-29.9%
14.8%
Q4 24
-26.0%
0.4%
Q3 24
-19.3%
-17.6%
Q2 24
-17.8%
-2.3%
Q1 24
-27.6%
-2.8%
EPS (diluted)
HCAT
HCAT
LIVE
LIVE
Q4 25
$-1.29
$-0.02
Q3 25
$-0.32
$-1.52
Q2 25
$-0.59
$1.24
Q1 25
$-0.35
$5.05
Q4 24
$-0.33
$0.16
Q3 24
$-0.24
$-6.31
Q2 24
$-0.23
$-0.91
Q1 24
$-0.35
$-1.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCAT
HCAT
LIVE
LIVE
Cash + ST InvestmentsLiquidity on hand
$95.7M
Total DebtLower is stronger
$153.3M
Stockholders' EquityBook value
$245.8M
$95.3M
Total Assets
$502.6M
$389.2M
Debt / EquityLower = less leverage
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCAT
HCAT
LIVE
LIVE
Q4 25
$95.7M
Q3 25
$91.5M
Q2 25
$97.3M
Q1 25
$342.0M
Q4 24
$392.0M
Q3 24
$387.3M
Q2 24
$308.3M
Q1 24
$327.8M
Total Debt
HCAT
HCAT
LIVE
LIVE
Q4 25
$153.3M
Q3 25
$153.1M
Q2 25
$153.0M
Q1 25
$382.9M
Q4 24
$382.4M
Q3 24
$345.0M
Q2 24
Q1 24
Stockholders' Equity
HCAT
HCAT
LIVE
LIVE
Q4 25
$245.8M
$95.3M
Q3 25
$331.9M
$95.3M
Q2 25
$347.5M
$94.3M
Q1 25
$376.8M
$88.9M
Q4 24
$365.2M
$73.3M
Q3 24
$355.0M
$72.9M
Q2 24
$357.0M
$92.7M
Q1 24
$357.2M
$95.9M
Total Assets
HCAT
HCAT
LIVE
LIVE
Q4 25
$502.6M
$389.2M
Q3 25
$587.1M
$386.4M
Q2 25
$616.2M
$387.5M
Q1 25
$891.5M
$393.6M
Q4 24
$858.9M
$395.5M
Q3 24
$813.0M
$407.5M
Q2 24
$691.7M
$436.8M
Q1 24
$695.1M
$433.9M
Debt / Equity
HCAT
HCAT
LIVE
LIVE
Q4 25
0.62×
Q3 25
0.46×
Q2 25
0.44×
Q1 25
1.02×
Q4 24
1.05×
Q3 24
0.97×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCAT
HCAT
LIVE
LIVE
Operating Cash FlowLast quarter
$9.9M
$9.8M
Free Cash FlowOCF − Capex
$9.6M
$8.5M
FCF MarginFCF / Revenue
12.9%
7.8%
Capex IntensityCapex / Revenue
0.4%
1.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-697.0K
$21.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCAT
HCAT
LIVE
LIVE
Q4 25
$9.9M
$9.8M
Q3 25
$-464.0K
$6.8M
Q2 25
$-9.0M
$12.3M
Q1 25
$280.0K
$231.0K
Q4 24
$-3.5M
$9.4M
Q3 24
$6.2M
$6.7M
Q2 24
$1.6M
$11.7M
Q1 24
$10.3M
$-5.7M
Free Cash Flow
HCAT
HCAT
LIVE
LIVE
Q4 25
$9.6M
$8.5M
Q3 25
$-719.0K
$4.8M
Q2 25
$-9.2M
$10.8M
Q1 25
$-390.0K
$-2.3M
Q4 24
$-3.9M
$7.6M
Q3 24
$5.5M
$3.3M
Q2 24
$1.3M
$10.1M
Q1 24
$10.1M
$-7.5M
FCF Margin
HCAT
HCAT
LIVE
LIVE
Q4 25
12.9%
7.8%
Q3 25
-0.9%
4.2%
Q2 25
-11.4%
9.6%
Q1 25
-0.5%
-2.1%
Q4 24
-4.9%
6.8%
Q3 24
7.2%
2.9%
Q2 24
1.7%
8.2%
Q1 24
13.5%
-6.3%
Capex Intensity
HCAT
HCAT
LIVE
LIVE
Q4 25
0.4%
1.2%
Q3 25
0.3%
1.7%
Q2 25
0.3%
1.3%
Q1 25
0.8%
2.3%
Q4 24
0.5%
1.6%
Q3 24
0.9%
3.1%
Q2 24
0.4%
1.3%
Q1 24
0.3%
1.4%
Cash Conversion
HCAT
HCAT
LIVE
LIVE
Q4 25
Q3 25
6.78×
Q2 25
2.28×
Q1 25
0.01×
Q4 24
19.11×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCAT
HCAT

Recurring Technology$51.9M69%
Professional Services$22.8M31%

LIVE
LIVE

Steel Manufacturing Segment$31.9M29%
Flooring Manufacturing Segment$28.9M27%
Retail Flooring Segment$25.3M23%
Retail Entertainment Segment$23.6M22%

Related Comparisons